REAMPLA 125 mg capsule, the energetic substance of which is palbociclib, respectively; It’s labeled as Antineoplastic and Immunomodulatory Brokers, Antineoplastics, Different Antineoplastics, Protein kinase inhibitors and Palbociclib, and is among the many licensed medicine within the Medicines and Medical Gadgets Company with the ATC code L01XE33. REAMPLA, which you’ll be able to acquire from the pharmacy with a traditional prescription, is a product of PFİZER PFE İLAÇLARI. Temporary data and prospectus paperwork for REAMPLA 125 mg (Indications, what drug it’s; What to comply with earlier than beginning REAMPLA, REAMPLA dosage; whether or not its use is appropriate for breastfeeding or pregnant ladies; interplay, drawbacks; advantages, storage circumstances; REAMPLA utilization; impact, undesirable-side results and suggestions and so forth. Issues to find out about REAMPLA 125 mg)
The put up REAMPLA 125 mg capsule first appeared on İlaç Net.
